Discover the beauty of Italian art through short videos featuring anecdotes and interesting facts about the most famous works of the Italian Renaissance. This is the aim of Menarini's "Pills of Art", a new multimedia project dedicated to the art world.

For these Australians that suffer from mild anxiety,1 the ‘always-on' and fast-paced nature of Aussie life appears to be a significant contributor with 90% admitting that they have experienced at least one symptom in the past month.1

A. Menarini Asia-Pacific Holdings Pte Ltd ("Menarini Asia-Pacific"), a member of the Italian largest biopharmaceutical company Menarini Group, and Orion Corporation have signed a multi-year licensing agreement for Menarini Asia-Pacific to distribute and commercialize several of Orion's Easyhaler® products in 10 countries in Asia-Pacific region.

Singapore, 29 June, 2018 - Singapore based A. Menarini Asia-Pacific Holdings Pte Ltd ("Menarini Asia-Pacific") and Daiichi Sankyo Co., Ltd. ("Daiichi Sankyo") have signed a multi-year exclusive licensing agreement for Menarini Asia-Pacific to assume the sales, marketing and distribution of the oral, once-daily, direct factor Xa inhibitor, edoxaban (brand name; LIXIANA®), in the Philippines, Malaysia and Singapore, following respective regulatory approvals in those countries.

Florence, 22/03/2018 - Pharmaceutical group Menarini, headed by the Aleotti family, has decided to entrust the Chairmanship of the company to an external manager coming from a large multinational, Dr. Eric Cornut. The new chairmanship will come into effect as of June.

The 17,000th employee in Menarini is Lara, 28 years old, a young graduate in Chemistry and Pharmaceutical Technology from the University of Florence, who is now employed in Menarini Ricerche.